WORLD authority on safety in drug manufacturing, United States Pharmacopeia (USP), has announced that this year they will be updating their standards for the compounding of medications in traditional compounding pharmacies.
USP is based in the United States, however it's standards are recognised as best practice worldwide and many Australian compounding pharmacies, including National Custom Compounding, maintain and calibrate their equipment and organise their documentation, according to them.
Specialist pharmacist Matthew Bellgrove from National Custom Compounding welcomed the news saying it would help to build trust in the sector.
"Anything that's designed to improve the standard of safety and quality in compounded medicine, or any medicine for that matter, is welcome as far as I'm concerned," Bellgrove said.
The standards currently being reviewed by USP include reducing the risk of contamination, infection or incorrect dosing of compounded sterile as well as nonsterile drugs.
This includes facilities, equipment, components, documentation, quality controls and training and much more.
The new standards are expected to be released by USP in Dec 2019.
The above article was sent to subscribers in Pharmacy Daily's issue from 27 Jun 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 27 Jun 18
